FDA-Inspected Site

Roswell Park Cancer Institute Corporation. Div. of Pathology

9 FDA inspections are on record for Roswell Park Cancer Institute Corporation. Div. of Pathology in Buffalo, United States.

Clean· No action indicated

Buffalo, United States · Last updated July 10, 2026

Overview

  • 9 FDA inspections are on record.
  • 1 inspection produced a Form 483.
  • The most recent recorded inspection date is 2025-09-19.

At a glance

Inspections

9

Form 483s

1

EIRs

0

Last outcome

Clean

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
16 Sep 2025 – 19 Sep 2025BiologicsClean
8 Mar 2023 – 13 Mar 2023BiologicsClean
26 Feb 2019 – 1 Mar 2019BiologicsClean
10 Jan 2017 – 13 Jan 2017BiologicsClean
16 Dec 2014 – 19 Dec 2014BiologicsClean
26 Feb 2013 – 1 Mar 2013BiologicsClean
17 Jun 2011Not recorded483View 483 →
23 Sep 2009Not recordedClean
2 Feb 2000Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

17 Jun 2011
21 CFR 211.100(b)

SOPs not followed / documented

Cited by Evelyn Taha

17 Jun 2011
21 CFR 211.194(a)(7)

Signatures and dates--person who performs test

Cited by Evelyn Taha

17 Jun 2011
21 CFR 211.194(a)(8)

Second person sign off

Cited by Evelyn Taha

17 Jun 2011
21 CFR 606.100(b)

Establish, maintain and follow manufacturing SOPs

Cited by Evelyn Taha

Investigators

FDA investigators tied to this site in the record.

James D Bridges1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.100(b)Cited across public-safe Form 483 observations1x
21 CFR 211.194(a)(7)Cited across public-safe Form 483 observations1x
21 CFR 211.194(a)(8)Cited across public-safe Form 483 observations1x
21 CFR 606.100(b)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind this site's 1 Form 483

Verbatim observations and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat